• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

GenomeDx Biosciences

edit

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Recent Milestones

edit

• 
  GenomeDx Biosciences received () in Series A funding. (1/9/12)
  Posted 1/9/12 at 8:39pm via finsmes.com

Videos

Screenshots

edit

Sources

1. GenomeDx Biosciences Closes Series A Financing Round (finsmes.com) [edit]